Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedA new publication citation by Yosipovitch et al. is added to the Publications section, detailing a post hoc analysis of JADE COMPARE and JADE DARE related to itch relief and quality of life in atopic dermatitis. This expands the study's referenced literature and author attribution.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s footer release/version label was updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor platform update rather than a change to the trial information.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page. The old revision tag v3.4.2 was removed and the new v3.4.3 tag added to reflect an update.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No study data or user-facing content is affected.SummaryDifference0.0%

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.